Phase 1 trial of KT‐333, a STAT3 degrader, in patients with relapsed or refractory lymphomas, large granular lymphocytic leukemia and solid tumors Meeting Abstract

  

Authors:	Smith, S.; Olszewski, A.; Starodub, A. N.; Stevens, D. A.; Feldman, T.; Porcu, P.; Epstein-Peterson, Z.; Huen, A.; Pinter‐Brown, L.; Mattour, A.; Perea, R.; Gollerkeri, A.; Dey, J.; Klaus, C.; Agarwal, S.; Gollob, J.; Shastri, A.
Abstract Title:	Phase 1 trial of KT‐333, a STAT3 degrader, in patients with relapsed or refractory lymphomas, large granular lymphocytic leukemia and solid tumors
Meeting Title:	17th International Conference on Malignant Lymphoma (ICML)
Journal Title:	Hematological Oncology
Volume:	41
Issue:	Suppl. 2
Meeting Dates:	2023 Jun 13-17
Meeting Location:	Lugano, Switzerland
ISSN:	0278-0232
Publisher:	Wiley Blackwell
Date Published:	2023-06-01
Start Page:	567
End Page:	568
Language:	English
DOI:	10.1002/hon.3164_424
PROVIDER:	EBSCOhost
PROVIDER:	cinahl
DOI/URL:	https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=cin20&AN=164231247&site=ehost-live&scope=site&custid=s2915669
Notes:	Meeting Abstract: 424 -- Source: Cinahl

https://synapse.mskcc.org/synapse/works/has_related_data_chk/207706